Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-07-21A Randomized Phase II Study of Interleukin-21 (rIL-21) Versus Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
-
CLINICAL_TRIALS study record update · 2014-07-18A Phase I/II Study of Isolated Limb Infusion and Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma
-
CLINICAL_TRIALS study record update · 2014-07-17A Phase 1 Clinical Trial of Intra-Tumoral Injection of Human IgM Monoclonal Antibody (MORAb-028) to the Ganglioside GD2 in Subjects With Injectable Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-07-16A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Radiologic Distribution of Ascending Single-Dose Radiolabeled MORAb-028 in Subjects With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-06-26Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-06-09A Multi-Center Phase II Study to Evaluate Tumor Response to Ipilimumab (BMS-734016) Monotherapy in Subjects With Melanoma Brain Metastases
-
CLINICAL_TRIALS study record update · 2014-06-04Phase II, Open-Label Trial in Patients With Stage IV Malignant Melanoma Using Melaxin as a Cancer Vaccine in Conjunction With BCG
-
CLINICAL_TRIALS study record update · 2014-06-03A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-06-02A Phase II (BRF113710) Single-arm, Open-label Study of GSK2118436 in BRAF Mutant Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-29Lymphokine Activated Killer (LAK) Cell Activity Against Cell Lines In-vitro of LAK Generated in Vivo by Pulse Interleukin-2 Therapy
-
CLINICAL_TRIALS study record update · 2014-05-22An Open Label Study of MDX-CTLA4 in Combination With Tyrosinase/gp100/MART-1 Peptides Emulsified With Montanide ISA 51 in the Treatment of Patients With Resected Stage III or IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-21A Randomized Phase II Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Resected Stages IIB/C, III, and IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-19A Phase I Trial of Vemurafenib and Ipilimumab in Subjects With V600 BRAF Mutation-positive Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-16Tailored Intervention for Melanoma Patient's Families
-
CLINICAL_TRIALS study record update · 2014-05-06ClinicalTrials.gov study NCT01066390
-
CLINICAL_TRIALS study record update · 2014-04-15A Multi-Center, Open-Label, Phase II Study of Ipilimumab (MDX-010 Extended-Treatment Monotherapy or Follow-up for Patients Previously Enrolled in Ipilimumab (MDX-010) Protocols.
-
CLINICAL_TRIALS study record update · 2014-04-10Phase 1 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-03-19A Phase 1 Study of the Safety and Efficacy of GC1008: A Human Anti Transforming Growth Factor-beta (TGFβ) Monoclonal Antibody in Patients With Advanced Renal Cell Carcinoma or Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2014-03-10A Multi-center, Randomized, Double-Blind, Two-Arm, Phase III Study in Patients With Untreated Stage III (Unresectable) or IV Melanoma Receiving Dacarbazine Plus 10 mg/kg Ipilimumab (MDX-010) vs. Dacarbazine With Placebo
-
CLINICAL_TRIALS study record update · 2014-03-07Brain Metastases Tissue Characterized by High-resolution Magic Angle Spinning MR and Micro Array
-
CLINICAL_TRIALS study record update · 2014-03-06A Two-Stage Trial of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-03-04A Randomized, Double-blind, Phase 3 Trial of Elesclomol (STA-4783) in Combination With Paclitaxel Versus Paclitaxel Alone for Treatment of Chemotherapy-Naïve Subjects With Stage IV Metastatic Melanoma (SYMMETRY)
-
CLINICAL_TRIALS study record update · 2014-02-28A Pilot Study of Neurocognitive Function in Patients Treated With Adjuvant Interferon Alpha-2b for High-Risk Melanoma
-
CLINICAL_TRIALS study record update · 2013-11-15Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-10-28Guidelines to the Intron A® Health Management Program II: A Nursing Support Program for Patients With High-Risk Melanoma Receiving High Dose Intron A Therapy